CDC Panel Recommends J&J Restart of COVID-19 Vaccine

The committee voted 10 to 4 to recommend use of the vaccine, with one abstention.

Meeting convened on April 23 and link above contains presentation slides.

NOTE: CDC Panel Members proposed that the FDA include a warning label that in rare cases the vaccine has caused clotting in women under 50.